ESC 365 - Value of annual NT-proBNP measurements to identify low-risk patients with asymptomatic aortic valve stenosis: An analysis from the randomized placebo-controlled SEAS trial

ESC Premium Access

Value of annual NT-proBNP measurements to identify low-risk patients with asymptomatic aortic valve stenosis: An analysis from the randomized placebo-controlled SEAS trial

Session: Late Breaking Science in Aortic Valve Stenosis

Topic: Aortic Valve Stenosis

Speaker: Professor O. Nielsen (Copenhagen, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Olav Wendelboe Nielsen

Copenhagen University Hospital, Copenhagen (Denmark)

1 presentation

0 follower

2 more presentations in this session

Prognostic implications of moderate aortic stenosis among 247,353 individuals: Insights from the National Echocardiography Database of Australia Study

Speaker: Professor G. Strange (Sydney, AU)

Incidence and Outcomes of Infective Endocarditis after Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement.

Speaker: Professor L. Fauchier (Tours, FR)

Access the full session

Late Breaking Science in Aortic Valve Stenosis

Speakers: Professor O. Nielsen, Professor G. Strange, Professor L. Fauchier

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources